Trade

with

Albany Molecular Research Inc
(NASDAQ: AMRI)
AdChoices
22.21
-0.24
-1.07%
After Hours :
22.21
0.00
0.00%

Open

22.65

Previous Close

22.45

Volume (Avg)

264.35k (307.08k)

Day's Range

22.12-23.18

52Wk Range

9.71-23.31

Market Cap.

721.34M

Dividend Rate ( Yield )

-

Beta

1.76

Shares Outstanding

32.48M

P/E Ratio (EPS)

43.29 (0.51)

AdChoices
Ownership

Institutional Ownership

-

Top 10 Institutions

57.74%

Mutual Fund Ownership

30.10%

Float

73.96%

5% / Insider Ownership

20.48%

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • DFA US Small Cap Value II Portfolio

  •  

    873,537

  • 0.00

  • 2.69

  • Royce Opportunity Fund

  •  

    700,710

  • -9.82

  • 2.16

  • iShares Core S&P Small-Cap (AU)

  •  

    472,990

  • 0.25

  • 1.44

  • Legg Mason Royce US Small Cap Opp

  •  

    435,000

  • 3.08

  • 1.34

  • iShares Nasdaq Biotechnology

  •  

    431,164

  • -0.69

  • 1.31

  • Vanguard Total Stock Mkt Idx

  •  

    395,242

  • 0.00

  • 1.22

  • iShares Russell 2000 (AU)

  •  

    368,137

  • -1.01

  • 1.12

  • DFA U.S. Micro Cap Portfolio

  •  

    345,122

  • 1.08

  • 1.06

  • SEB Concept BioTech

  •  

    263,200

  • 14.63

  • 0.81

  • Vanguard Extended Market Index Fund

  •  

    252,356

  • 0.00

  • 0.78

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • Bessemer Trust Co Of Delaware, N.a.

  •  

    4,293,289

  • -5.96%

  • 13.27

  • Dimensional Fund Advisors, Inc.

  •  

    2,716,245

  • +3.31%

  • 8.38

  • Visium Asset Management LLC

  •  

    2,170,000

  • -31.11%

  • 6.69

  • Wellington Management Company, LLP

  •  

    1,564,852

  • -6.66%

  • 4.83

  • BlackRock Fund Advisors

  •  

    1,519,059

  • +46.82%

  • 4.69

  • Evercore Wealth Management, LLC

  •  

    1,331,480

  • 0.00%

  • 4.11

  • Royce & Associates, LLC

  •  

    1,315,610

  • -2.16%

  • 4.06

  • Acadian Asset Management LLC

  •  

    1,259,249

  • 0.00%

  • 3.88

  • Millennium Management LLC

  •  

    910,133

  • -10.96%

  • 2.81

Company Profile

Sector

Healthcare

Industry

Biotechnology

Type

Speculative Growth

Style

Small Growth

Albany Molecular Research Inc is a Delaware corporation incorporated on June 20, 1991. It is a contract research and manufacturing organization providing customers integrated drug discovery, development and manufacturing services. Th...moree Company provides services and technologies that support the discovery and development of pharmaceutical products and the manufacturing of Active Pharmaceutical Ingredients (API) and drug product for existing and experimental new drugs, as well as research, development and manufacturing for the agrochemical and other industries. With locations in the United States, Europe, and Asia, it maintains geographic proximity and flexible cost models. The Company has organized its activities into two distinct segments: Large Scale Manufacturing (LSM) and Discovery, Drug Developme...morent and Small-Scale Manufacturing (DDS). Its LSM activities include pilot- to commercial-scale production of active pharmaceutical ingredients and intermediates, sterile syringe and vial filling, and high potency and controlled substance manufacturing. Its remaining activities, including drug lead discovery, in vitro biology and DMPK, lead optimization, drug development, and small-scale commercial manufacturing, represent its DDS business segment. Its Drug Discovery Services includes assay development and design, screening, natural product services, custom synthesis and library synthesis, medicinal chemistry, bioanalytical services, among others. Its customers include pharmaceutical companies and biotechnology companies, as well as government research entities and non-profit organizations, which are a growing segment of its customer base. It also sells to a more limited extent, to companies who are in the businesses of agriculture, fine chemicals, contract chemical manufacturing, medical devices, and flavoring and cosmetics. The Company competes with contract research companies, contract drug manufacturing companies, research and academic institutions and with the internal research departments of biotechnology companies. The manufacture, transportation and storage of its products are subject to certain international, Federal, state and local laws and regulations.lessless

Key People

William S. Marth

CEO/Director/President

Dr. Thomas E. D'Ambra,PhD

Chairman of the Board/Co-Founder/Director

Mr. Michael Nolan

CFO/Chief Accounting Officer/Treasurer/Senior Vice President

Mr. Brian D. Russell

Vice President, Divisional

Arthur J. Roth

Director

Incorporated

1991

Employees

-

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: